Help
Posted Wed, Mar, 21,2012
Libertas Academica has been using Twitter since February 2010 to benefit readers and authors.
As a reader, by following Immunotherapy Insights on Twitter you will be notified about new articles in your field of expertise, calls for papers, Editorial announcements, and any other important updates for the journal.
We post on Twitter within minutes of a paper being published so Twitter followers are the first people to view new articles.
For authors our Twitter services offer your article even greater visibility. Libertas Academica uses Twitter because it’s visibility and popularity gives us the opportunity to inform thousands of people about new articles published.
Visit the Immunotherapy Insights Twitter feed
What is Twitter?
Twitter is one of the most popular and user-friendly social media sites on the internet.
By following Immunotherapy Insights on Twitter, you can receive e-mail, SMS and website notifications of new articles and other important updates.
We make sure that readers are kept up to date with the latest news and publications for all of our journals, and can reach over 7,000 Twitter subscribers.
See our full list of Twitter services
Posted in: Social Media
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesIt is my pleasure to confirm that we had a very pleasant experience by publishing our article in Clinical Medicine Insights: Therapeutics. The review process was highly efficient and the reviewers' comments useful and constructive. I am sure that this is the kind of publication needed by the scientific community. I am looking forward future collaborations.
Facebook Google+ Twitter
Pinterest Tumblr YouTube